3mL cartridge 100units/mL
3mL prefilled disposable Pen 100units/mL

First choice in new users

10mL vial
3mL cartridge for OptiPen® Pro 1
3mL prefilled disposable pen SoloSTAR®

Lantus® brand is not a preferred product in the LSCMMG antihyperglycaemics guideline. Biosimilars of Insulin glargine are also available for the treatment of NEW patients and patients assessed to need a medication change. Treatment should normally be started with the least expensive drug.

Pre-filled pen 300 units/mL

First line high strength long acting insulin (Toujeo Solostar)

Type 1 - in accordance with the recommendations in NICE NG17 and in those who experience an unacceptable frequency and/or severity of nocturnal hypoglycaemia on attempting to achieve better glycaemic control during treatment with first-line long-acting insulin analogues; or as a once daily insulin therapy for patients who require assistance with administering injections.

Type 2 - in accordance with the recommendations in NICE NG28 in those who suffer from symptomatic nocturnal hypoglycaemia whilst being treated with a first-line long-acting insulin analogue.

100 units/ml 3ml cartridges
100units/ml pre-filled pens Flextouch
200units/ml pre-filled pens Flextouch

Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin
Specialists may exceptionally consider initiating insulin degludec if:
- Patient is experiencing poor glycaemic control or recurrent hypoglycaemic episodes with their existing long-acting insulin analogue or
- Patient is unable to take basal insulin at the same time each day

Second line high strength long-acting (Tresiba FlexTouch 200).
Third line long acting insulin analogue (Tresiba Flextouch 100).